In collaboration with Dr. Einav Gal-Yam, Sheba Cancer Center

Monoclonal antibodies are widely used in for treatment of specific types of tumors.

Our goal is to understand the natural antibody immune response against tumors in breast and lung cancer patients by isolating naturally produced antibodies against tumor-associated antigens (TAA). We use single cell antibody sequencing methods for discovery of new anti-tumor antibodies that can potentially be used in the clinic for diagnostic and treatment of patients.